Health services research

Pathway Health Launches Learning Institute and Education Advisory Board

Retrieved on: 
Wednesday, March 6, 2024

LAKE ELMO, Minn., March 06, 2024 (GLOBE NEWSWIRE) -- Pathway Health , a leading health care consulting services, interim and permanent talent, technology implementation, and training company, announces the launch of the Pathway Learning Institute.

Key Points: 
  • LAKE ELMO, Minn., March 06, 2024 (GLOBE NEWSWIRE) -- Pathway Health , a leading health care consulting services, interim and permanent talent, technology implementation, and training company, announces the launch of the Pathway Learning Institute.
  • The Pathway Learning Institute will draw upon the expertise of Pathway Health’s nationally recognized education and training programs, complemented by insights from top subject matter experts in senior care.
  • Guiding the efforts of the Pathway Learning Institute is an esteemed Education Advisory Board, playing a crucial role in providing insight and direction for overarching principles and processes.
  • Additionally, the board will ensure the expertise of subject matter experts involved in the review of courses eligible for Pathway Board Certification Education.

VRx Health Launches Xaia on Apple Vision Pro, Combining Spatial Computing and AI for Mental Health Support

Retrieved on: 
Friday, February 2, 2024

LOS ANGELES, Feb. 2, 2024 /PRNewswire/ -- Today, VRx Health, pioneers of medical extended reality, announced the launch of Xaia (eXtended reality Artificially Intelligent Ally), a first-of-its-kind app combining spatial computing with AI for personalized mental health. Xaia's technology has been exclusively licensed from Cedars-Sinai to VRx Health, to bring immersive AI therapy to the world.

Key Points: 
  • LOS ANGELES, Feb. 2, 2024 /PRNewswire/ -- Today, VRx Health, pioneers of medical extended reality, announced the launch of Xaia (eXtended reality Artificially Intelligent Ally), a first-of-its-kind app combining spatial computing with AI for personalized mental health.
  • Xaia's technology has been exclusively licensed from Cedars-Sinai to VRx Health, to bring immersive AI therapy to the world.
  • Currently, Xaia is available as an application on Apple Vision Pro headsets.
  • Designed to take advantage of the powerful capabilities of visionOS, Xaia is experienced via spatial computing on Vision Pro and visualized as a human-scale, 3D robot.

Imagine Pharma Launches the Imagine Pharma Foundation to Advance Metabolic Research with a Focus on Veterans

Retrieved on: 
Tuesday, January 23, 2024

PITTSBURGH, Jan. 23, 2024 /PRNewswire/ -- Imagine Pharma, a biotech company focused on furthering the commercialization opportunities related to its novel IMG-1 polypeptide across three distinct platforms: Oral Delivery, Therapeutics, and Regenerative Medicine, announced today the formation of The Imagine Pharma Foundation, a private not for profit charitable organization dedicated to advancing metabolic research to significantly impact the lives of those affected by diabetes, with a particular emphasis on serving veterans.

Key Points: 
  • The Imagine Pharma Foundation will collaborate with leading research institutions, pharmaceutical companies, healthcare providers, and other non-profit organizations, with a focus on four key areas: advancement of metabolic and diabetes research, increasing access to cutting-edge treatments for veterans and communities in need, supporting other non-profits focused on metabolic research and care and implementing education and awareness programs on diabetes prevention.
  • Diabetes is a major global health concern, affecting nearly 25 percent of the Department of Veterans Affairs (VA) patient population.
  • The disease is also the leading cause of blindness, end-stage renal disease, and amputation for VA patients.
  • "Through cutting-edge research, collaboration and education, we aim to play a leading role in advancing research and treatment for diabetes and other metabolic diseases to help improve outcomes for those with this disease."

Sleep Number Unveils New Research Linking Sleep Abnormalities with Risk of Heart Failure

Retrieved on: 
Tuesday, October 17, 2023

The study, titled "Sleep Abnormalities Among Community Participants at Risk for Heart Failure," leveraged longitudinal sleep data from Sleep Number smart beds with Mayo Clinic’s AI capabilities and clinical expertise.

Key Points: 
  • The study, titled "Sleep Abnormalities Among Community Participants at Risk for Heart Failure," leveraged longitudinal sleep data from Sleep Number smart beds with Mayo Clinic’s AI capabilities and clinical expertise.
  • View the full release here: https://www.businesswire.com/news/home/20231016764432/en/
    Today, Sleep Number Corporation announced new research presented at the Heart Failure Society of America Annual Scientific Meeting in Cleveland.
  • Data presented show results of a study in collaboration with investigators at Mayo Clinic analyzing the connection between sleep abnormalities and heart failure with preserved ejection fraction (HFpEF), the most common cause of heart failure.
  • “By connecting sleep disturbances and HFpEF risk, this study could suggest that addressing sleep issues may potentially play a role in preventing or managing heart failure,” said Raj Mills, Vice President, SleepIQ Health and Research, Sleep Number.

Market Access and Government Affairs Executive Joins NDA Partners as Expert Consultant

Retrieved on: 
Thursday, September 14, 2023

WASHINGTON, Sept. 14, 2023 /PRNewswire-PRWeb/ -- NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Michele Schoonmaker, a Market Access and Government Affairs executive, has joined the firm as an Expert Consultant. Dr. Schoonmaker is a recognized leader in Market Access and Government Affairs strategy and advocacy with over 25 years of experience driving coordinated, innovative solutions to complex reimbursement, regulatory, and other policy issues to accelerate commercialization of and patient access to state-of-the-art molecular diagnostic tests. She joins the firm to provide strategic solutions to complex market access and/or government affairs problems facing companies or laboratories seeking to bring new diagnostic tests to market.

Key Points: 
  • NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Michele Schoonmaker, a Market Access and Government Affairs executive, has joined the firm as an Expert Consultant.
  • Most recently, Dr. Schoonmaker served as Senior Vice President with Cephid where she built and led the Government Affairs and Market Access function.
  • WASHINGTON, Sept. 14, 2023 /PRNewswire-PRWeb/ -- NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Michele Schoonmaker , a Market Access and Government Affairs executive, has joined the firm as an Expert Consultant.
  • She joins the firm to provide strategic solutions to complex market access and/or government affairs problems facing companies or laboratories seeking to bring new diagnostic tests to market.

Christopher E. Johnson Appointed Director of Georgia State’s Institute for Health Administration

Retrieved on: 
Tuesday, August 8, 2023

Atlanta, Georgia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Christopher E. Johnson has been appointed Joe Taylor Director of the Institute of Health Administration at Georgia State University’s J. Mack Robinson College of Business.

Key Points: 
  • Atlanta, Georgia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Christopher E. Johnson has been appointed Joe Taylor Director of the Institute of Health Administration at Georgia State University’s J. Mack Robinson College of Business.
  • A renowned health services research, policy, and administration scholar, Johnson has deep expertise in investigating healthcare organizations and healthcare outcomes for veterans, underserved populations, and the elderly.
  • “We are thrilled Chris Johnson will lead the Institute for Health Administration,” said Richard D. Phillips, dean of the Robinson College.
  • Johnson holds a doctorate in health services research, policy, and administration from the University of Minnesota and is a graduate of the U.S.

New Chief Health Officer/Chief Medical Officer at Community Health Plan of Washington (CHPW) to Lead Whole-Person Care Delivery

Retrieved on: 
Wednesday, July 19, 2023

Community Health Plan of Washington (CHPW) , the not-for-profit Washington-based managed-care organization, has hired Demetria Malloy, MD, MSHS as the new Chief Health Officer/Chief Medical Officer.

Key Points: 
  • Community Health Plan of Washington (CHPW) , the not-for-profit Washington-based managed-care organization, has hired Demetria Malloy, MD, MSHS as the new Chief Health Officer/Chief Medical Officer.
  • CHPW currently cares for more than 300,000 Washingtonians who have its Apple Health (Medicaid), Medicare Advantage, and public-option Individual and Family health plans.
  • View the full release here: https://www.businesswire.com/news/home/20230719310397/en/
    Demetria Malloy, MD, MSHS, has been hired as the new Chief Health Officer/Chief Medical Officer for not-for-profit Washington-based managed-care organization Community Health Plan of Washington (CHPW).
  • “I am very excited to be joining Community Health Plan of Washington to build on its focus on innovative care solutions for members, especially for those experiencing the greatest health disparities,” said Malloy.

American Institutes for Research Experts to Present at AcademyHealth Annual Research Meeting

Retrieved on: 
Monday, June 5, 2023

Arlington, Va., June 05, 2023 (GLOBE NEWSWIRE) -- Arlington, Va. – Health experts from the American Institutes for Research (AIR) will present and share findings at AcademyHealth’s 2023 Annual Research Meeting (ARM), being held June 24-27 in Seattle, Washington.

Key Points: 
  • Arlington, Va., June 05, 2023 (GLOBE NEWSWIRE) -- Arlington, Va. – Health experts from the American Institutes for Research (AIR) will present and share findings at AcademyHealth’s 2023 Annual Research Meeting (ARM), being held June 24-27 in Seattle, Washington.
  • AcademyHealth is a leading national organization serving the fields of health services and policy research.
  • Health Services Research is an official publication of AcademyHealth and Devers serves on its editorial board.
  • Learn more about AIR's work in health and the H ealth Research & Policy Center .

OneOncology Presents Abstracts at ASCO Highlighting Importance of Increasing NGS Testing

Retrieved on: 
Thursday, May 25, 2023

Seventy-nine percent were treated in the community setting, and 56 percent received NGS testing.

Key Points: 
  • Seventy-nine percent were treated in the community setting, and 56 percent received NGS testing.
  • "Our research points to the need for systematic program interventions and policies to improve timely access to NGS testing among Black and Latinx patients."
  • Dr. Vidal's research builds upon earlier OneOncology research , that showed OneOncology had a higher NGS uptake with a shorter time to testing in metastatic breast cancer than non-OneOncology community cancer centers, possibly related to OneOncology's network-wide strategy recommending NGS testing at diagnosis of advanced disease.
  • These studies highlight the importance of built-in processes that recommend NGS testing and alert physicians when additional testing may be necessary—an effort that is actively being led by OneOncology's Precision Medicine team.

Flo's reproductive health survey reveals stark knowledge gaps amongst UK women

Retrieved on: 
Thursday, May 11, 2023

LONDON, May 11, 2023 /PRNewswire/ -- Flo Health, the most popular women's health app globally with 50 million monthly active users, has released the findings of a nationwide survey of women aged 18–55, highlighting a staggering degree of misinformation and prominent gaps in the knowledge women have about their own bodies.

Key Points: 
  • Flo's nationwide survey on the state of health literacy shows that 56% of UK women rely on generic advice from search engines for menstrual health information.
  • 72% of women never double-check the health information they get on social media, while nearly one in five (18%) women aged 18–24 go to social media for information around menstrual health.
  • Flo Health's 2023 UK Reproductive Health survey of 2,000 UK women aged 18–66 was commissioned by Flo Health and conducted by market research company OnePoll, in accordance with the Market Research Society's code of conduct.
  • Flo Health's 2023 US Reproductive Health survey was conducted in January 2023 among 2,010 online adult women ages 18–55 via Cint.